World's Best Scientists 2026 revealed!
Annals of Clinical Microbiology and Antimicrobials
H-index 19

Annals of Clinical Microbiology and Antimicrobials

1476-0711

Published by: Springer

https://ann-clinmicrob.biomedcentral.com/

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Microbiology 172 48 50 12

Additional Metrics

Number of Best Scientists*: 107
Documents by Best Scientists*: 108
Top 100 Ranked Scientists*: 4
SCIMAGO H-index: 75
SCIMAGO SJR: 0.968
Impact Factor: 3.6

Overview

Top Research Topics at Annals of Clinical Microbiology and Antimicrobials?

The main research concerns discussed in the journal are Drug resistance, Microbiology, Medical microbiology, Internal medicine and Parasitology. The research on Drug resistance featured in Annals of Clinical Microbiology and Antimicrobials combines topics in other fields like Antibiotics, Antibiotic resistance, Antimicrobial, Pseudomonas aeruginosa and Genotype. Antibiotic resistance study tackled is connected to the field of Ampicillin.

It focuses on Microbiology but the discussions also offer insight into other areas such as Vancomycin, Staphylococcus aureus, Bacteria and Virology. Staphylococcal infections, Methicillin-resistant Staphylococcus aureus and SCCmec are Staphylococcus aureus topics of special interest in Annals of Clinical Microbiology and Antimicrobials. The Medical microbiology works featured in it incorporate elements from Epidemiology, Disease, Tuberculosis and Intensive care medicine.

The Tuberculosis study tackling the subject of Mycobacterium tuberculosis is the focus of the journal. Annals of Clinical Microbiology and Antimicrobials explores topics in Internal medicine which can be helpful for research in disciplines like Gastroenterology, Surgery and Bacteremia. Most of the Multiple drug resistance studies addressed also intersect with Acinetobacter baumannii.

  • Drug resistance (58.76%)
  • Microbiology (53.43%)
  • Medical microbiology (39.97%)

What are the most cited papers published in the journal?

  • Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India (337 citations)
  • Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States (330 citations)
  • Community-acquired MRSA and pig-farming. (320 citations)

Research areas of the most cited articles at Annals of Clinical Microbiology and Antimicrobials:

The journal publications focus largely on the fields of Microbiology, Drug resistance, Medical microbiology, Antibiotics and Antimicrobial. In addition to Microbiology research, the published articles aim to explore topics under Vancomycin, Staphylococcus aureus, Bacteria and Virology. The journal articles focus on Drug resistance but the discussions also offer insight into other areas such as Internal medicine, Klebsiella pneumoniae and Antibiotic resistance, Imipenem.

What topics the last edition of the journal is best known for?

  • Bacteria
  • Antibiotics
  • Internal medicine

The previous edition focused in particular on these issues:

The journal covers a variety of subjects, including Drug resistance, Microbiology, Medical microbiology, Antibiotic resistance and Internal medicine. Drug resistance research presented in Annals of Clinical Microbiology and Antimicrobials encompasses a variety of subjects, including Genotype, Antibiotics, Antimicrobial and Klebsiella pneumoniae. The studies on Microbiology discussed can also contribute to research in the domains of Escherichia coli, Multilocus sequence typing and Biofilm.

Issues in Medical microbiology were discussed, taking into consideration concepts from other disciplines like Epidemiology, Parasitology, Incidence (epidemiology), Carriage and Pandemic. Antibiotic resistance research featured in it incorporates concerns from various other topics such as Erythromycin, Sputum and Teicoplanin. It tackles studies in Staphylococcus aureus and the interrelated subject of Prospective cohort study to gain insights into Internal medicine.

The most cited articles from the last journal are:

  • COVID-19: breaking down a global health crisis. (12 citations)
  • Clinical characteristics and predictors of mortality in young adults with severe COVID-19: a retrospective observational study. (8 citations)
  • MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Annals of Clinical Microbiology and Antimicrobials (based on the number of publications) are:

  • Hakan Leblebicioglu (20 papers) absent at the last edition,
  • Alfonso J. Rodriguez-Morales (13 papers) published 1 paper at the last edition, 4 less than at the previous edition,
  • Niyaz Ahmed (9 papers) absent at the last edition,
  • Feleke Moges (7 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • Leonardo Antonio Sechi (7 papers) published 1 paper at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Annals of Clinical Microbiology and Antimicrobials (based on the number of publications) are:

  • Ondokuz Mayıs University (24 papers) absent at the last edition,
  • Tribhuvan University (12 papers) published 2 papers at the last edition, 1 less than at the previous edition,
  • Technological University of Pereira (12 papers) published 1 paper at the last edition, 4 less than at the previous edition,
  • King Saud University (11 papers) absent at the last edition,
  • Boston Children's Hospital (11 papers) published 3 papers at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.78% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.86% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.43% of all publications and 55.71% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes.

    Toyin Togun;Beate Kampmann;Neil Graham Stoker;Marc Lipman;Marc Lipman

    (2020)
    250 Citations
  • The challenging management of Rift Valley Fever in humans: literature review of the clinical disease and algorithm proposal

    (2020)
    78 Citations
  • Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by MALDI-TOF-MS.

    Léa Ponderand;Léa Ponderand;Patricia Pavese;Danièle Maubon;Danièle Maubon;Emmanuelle Giraudon

    (2020)
    40 Citations
  • In vitro activity of ceftazidime–avibactam and comparators against Gram-negative bacterial isolates collected in the Asia–Pacific region as part of the INFORM program (2015–2017)

    (2020)
    37 Citations
  • A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes.

    Sulochana Manandhar;Sulochana Manandhar;Raphael M. Zellweger;Raphael M. Zellweger;Nhukesh Maharjan;Sabina Dongol

    (2020)
    35 Citations
  • Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.

    Seyedesomaye Jasemi;Mohammad Emaneini;Zahra Ahmadinejad;Mohammad Sadegh Fazeli

    (2021)
    25 Citations
  • Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.

    Negin Bolourchi;Fereshteh Shahcheraghi;Christian G. Giske;Shoeib Nematzadeh

    (2021)
    18 Citations
  • Genomic insights into virulence factors affecting tissue-invasive Klebsiella pneumoniae infection

    (2022)
    17 Citations
  • BioFire FilmArray Pneumonia Panel enhances detection of pathogens and antimicrobial resistance in lower respiratory tract specimens

    (2022)
    14 Citations
  • Compassionate use of a novel β-lactam enhancer-based investigational antibiotic cefepime/zidebactam (WCK 5222) for the treatment of extensively-drug-resistant NDM-expressing Pseudomonas aeruginosa infection in an intra-abdominal infection-induced sepsis patient: a case report

    (2023)
    14 Citations

Best Scientists Contributing to This Journal